Open Access to Psychedelic Science
A curated index of peer-reviewed psychedelic research, clinical trial results, and open-access literature — free for clinicians, researchers, and the curious.
Curated Clinical Trial Data
Opendelic aggregates Phase 2 and Phase 3 trial results for psilocybin-assisted therapy, MDMA for PTSD, and ketamine infusion protocols. Each entry links directly to the primary publication or ClinicalTrials.gov record for full transparency.
Harm Reduction and Safety Guides
Evidence-based harm reduction resources inform safe practice. Our guides cover drug interactions, contraindications, set-and-setting principles, and integration support — grounded in current research, not anecdote.
Frequently asked questions
- Is Opendelic affiliated with any pharmaceutical company?
- No. Opendelic is an independent resource. We have no commercial ties to any drug manufacturer or clinical sponsor.
- Can researchers submit studies for inclusion?
- Yes. Submit published, peer-reviewed work via our contact form. We review and index eligible submissions within two weeks.
- Is the research library free to access?
- Entirely free. All indexed resources are open-access or link to freely available abstracts and full texts.
Get in touch
Contact the Opendelic team to submit research, report broken links, or propose collaboration. We respond within two business days.
research@opendelic.com